HYDROCORTISONE SODIUM SUCCINATE

HYDROCORTISONE SODIUM SUCCINATE was reported 3992 times

HYDROCORTISONE SODIUM SUCCINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 52 0.2271
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 130 0.1946
2 LUPUS VULGARIS 229 0.1817
3 MECHANICAL VENTILATION COMPLICATION 27 0.1812
4 SWOLLEN JOINT COUNT 42 0.1680
5 C-REACTIVE PROTEIN 153 0.1650
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 302 0.1508
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 299 0.1442
8 RETINITIS 249 0.1440
9 ACQUIRED PORPHYRIA 10 0.1408
10 DISLOCATION OF VERTEBRA 319 0.1397
11 X-RAY ABNORMAL 250 0.1397
12 SWOLLEN JOINT COUNT INCREASED 422 0.1322
13 NIPPLE SWELLING 32 0.1275
14 SERONEGATIVE ARTHRITIS 143 0.1248
15 RHEUMATIC FEVER 551 0.1235
16 FACET JOINT SYNDROME 382 0.1172
17 PORPHYRIA ACUTE 162 0.1129
18 INSPIRATORY CAPACITY DECREASED 25 0.0903
19 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 46 0.0820
20 HEPATIC ENZYME 12 0.0805
21 RHEUMATOID FACTOR POSITIVE 459 0.0794
22 DUODENAL ULCER PERFORATION 525 0.0705
23 HYPOCHOLESTEROLAEMIA 22 0.0623
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 391 0.0601
25 HELICOBACTER INFECTION 597 0.0580
26 PERIPHERAL VENOUS DISEASE 226 0.0553
27 BONE EROSION 191 0.0540
28 C-REACTIVE PROTEIN ABNORMAL 345 0.0537
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 377 0.0526
30 MUSCLE INJURY 433 0.0522
31 FOLLICULITIS 512 0.0488
32 HUMAN BOCAVIRUS INFECTION 9 0.0476
33 HAND DEFORMITY 624 0.0475
34 MYCOBACTERIUM CHELONAE INFECTION 35 0.0474
35 PEMPHIGUS 534 0.0427
36 DRUG TOLERANCE DECREASED 112 0.0398
37 WOUND INFECTION 434 0.0396
38 LIP DRY 355 0.0390
39 JOINT RANGE OF MOTION DECREASED 518 0.0386
40 BREAST CANCER STAGE III 243 0.0375
41 GRIP STRENGTH DECREASED 329 0.0373
42 HYPERCHOLESTEROLAEMIA 360 0.0372
43 STEROID DEPENDENCE 31 0.0353
44 SYNOVITIS 590 0.0327
45 PERICARDITIS 543 0.0323
46 ENGRAFT FAILURE 9 0.0314
47 LUPUS-LIKE SYNDROME 273 0.0301
48 CATARRH 27 0.0299
49 WALKING AID USER 194 0.0294
50 AUTOIMMUNE DISORDER 275 0.0282
51 GLOSSODYNIA 626 0.0279
52 SCIATICA 426 0.0267
53 DISABILITY ASSESSMENT SCALE SCORE INCREASED 8 0.0261
54 IRRITABLE BOWEL SYNDROME 558 0.0260
55 JOINT DISLOCATION 275 0.0260
56 MATERNAL EXPOSURE TIMING UNSPECIFIED 96 0.0255
57 ENTEROCOCCUS TEST POSITIVE 16 0.0247
58 ADRENOCORTICAL INSUFFICIENCY ACUTE 48 0.0246
59 EXOSTOSIS 222 0.0243
60 WOUND 657 0.0235
61 CORONA VIRUS INFECTION 10 0.0233
62 BURSITIS 281 0.0231
63 SECONDARY IMMUNODEFICIENCY 28 0.0230
64 FIBROMYALGIA 557 0.0229
65 WHITE COAT HYPERTENSION 12 0.0221
66 ABSCESS BACTERIAL 8 0.0220
67 RED BLOOD CELL SEDIMENTATION RATE INCREASED 223 0.0201
68 SYNOVIAL DISORDER 9 0.0198
69 FOOT DEFORMITY 219 0.0197
70 IMPAIRED HEALING 637 0.0194
71 INFUSION RELATED REACTION 1275 0.0192
72 LOWER LIMB FRACTURE 357 0.0186
73 ONYCHOMADESIS 77 0.0183
74 TYPE 2 DIABETES MELLITUS 615 0.0182
75 SYSTEMIC LUPUS ERYTHEMATOSUS 644 0.0181
76 LIVE BIRTH 144 0.0172
77 SPONDYLITIS 62 0.0170
78 HIP ARTHROPLASTY 254 0.0166
79 EPIGLOTTITIS 9 0.0165
80 PULMONARY FIBROSIS 312 0.0162
81 LIVER INJURY 398 0.0162
82 NIPPLE PAIN 33 0.0162
83 ONYCHOMYCOSIS 71 0.0162
84 PRESCRIBED OVERDOSE 312 0.0161
85 OVERLAP SYNDROME 11 0.0157
86 OBESITY 250 0.0157
87 SPINAL FUSION SURGERY 63 0.0155
88 ENGRAFTMENT SYNDROME 9 0.0152
89 PRESCRIBED UNDERDOSE 299 0.0150
90 BURNS SECOND DEGREE 26 0.0148
91 STEROID WITHDRAWAL SYNDROME 15 0.0147
92 PSORIATIC ARTHROPATHY 593 0.0146
93 PHARYNGEAL PARAESTHESIA 22 0.0139
94 PUSTULAR PSORIASIS 45 0.0131
95 HEPATIC CIRRHOSIS 241 0.0128
96 BLEPHAROSPASM 75 0.0119
97 BASOPHIL COUNT INCREASED 9 0.0119
98 CYTOMEGALOVIRUS CHORIORETINITIS 23 0.0118
99 CYTOMEGALOVIRUS VIRAEMIA 50 0.0112
100 CYTOMEGALOVIRUS TEST POSITIVE 20 0.0112
101 PARAINFLUENZAE VIRUS INFECTION 17 0.0112
102 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 8 0.0111
103 FUNGAEMIA 17 0.0108
104 JOINT STIFFNESS 283 0.0108
105 WHEEZING 628 0.0106
106 KNEE ARTHROPLASTY 222 0.0105
107 RASH VESICULAR 50 0.0103
108 BREAST CANCER STAGE II 85 0.0102
109 VEIN RUPTURE 17 0.0101
110 DELIRIUM 352 0.0101
111 NIGHT SWEATS 323 0.0100
112 HAEMOTHORAX 29 0.0100
113 ROAD TRAFFIC ACCIDENT 409 0.0098
114 JOINT DESTRUCTION 15 0.0096
115 CONTRAINDICATED PRODUCT ADMINISTERED 290 0.0096
116 SINUSITIS BACTERIAL 10 0.0095
117 INFUSION SITE REACTION 28 0.0094
118 FREQUENT BOWEL MOVEMENTS 253 0.0094
119 DEATH NEONATAL 13 0.0093
120 OSTEOARTHRITIS 394 0.0093
121 EAR INFECTION 246 0.0092
122 GAIT INABILITY 304 0.0091
123 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0090
124 C-REACTIVE PROTEIN INCREASED 329 0.0090
125 LIVER DISORDER 397 0.0089
126 WEIGHT FLUCTUATION 93 0.0089
127 HEPATIC ENZYME INCREASED 602 0.0088
128 INJURY 618 0.0088
129 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
130 NECROTISING COLITIS 11 0.0087
131 HYPOPNOEA 30 0.0086
132 ADRENAL INSUFFICIENCY 104 0.0086
133 OEDEMA 464 0.0085
134 ARTHROPATHY 471 0.0085
135 HUMAN HERPESVIRUS 6 INFECTION 16 0.0085
136 ENTEROBACTER INFECTION 14 0.0083
137 BLOOD PRESSURE DIASTOLIC ABNORMAL 21 0.0082
138 STOMATITIS 500 0.0082
139 INFLAMMATION 425 0.0082
140 BLOOD CHOLESTEROL INCREASED 383 0.0082
141 LOWER RESPIRATORY TRACT INFECTION 371 0.0081
142 DRUG LEVEL BELOW THERAPEUTIC 44 0.0080
143 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 14 0.0079
144 DISCOMFORT 473 0.0077
145 DISABILITY 153 0.0077
146 INSULIN-LIKE GROWTH FACTOR INCREASED 11 0.0077
147 BLISTER 431 0.0077
148 BLOOD PRESSURE FLUCTUATION 184 0.0077
149 DISSEMINATED INTRAVASCULAR COAGULATION 105 0.0075
150 INTENTIONAL PRODUCT USE ISSUE 647 0.0074
151 ILL-DEFINED DISORDER 446 0.0073
152 SINUS PAIN 17 0.0073
153 LIVER FUNCTION TEST INCREASED 156 0.0073
154 THERAPEUTIC PRODUCT EFFECT DECREASED 322 0.0072
155 LUNG DISORDER 350 0.0071
156 ALCOHOL POISONING 19 0.0071
157 SUSPECTED OFF LABEL USE 32 0.0071
158 OVARIAN CYST RUPTURED 9 0.0070
159 DRUG LEVEL ABOVE THERAPEUTIC 32 0.0070
160 OSTEOPOROSIS 285 0.0069
161 SCLERITIS 11 0.0069
162 PSEUDOMEMBRANOUS COLITIS 15 0.0067
163 DIABETES INSIPIDUS 16 0.0066
164 NORMAL NEWBORN 36 0.0066
165 EYE INJURY 20 0.0066
166 EAR PRURITUS 23 0.0066
167 SWELLING 609 0.0065
168 POOR VENOUS ACCESS 67 0.0065
169 MUSCULOSKELETAL STIFFNESS 560 0.0064
170 MOBILITY DECREASED 458 0.0064
171 ANAL FISSURE 34 0.0063
172 BLOOD PRESSURE DIASTOLIC INCREASED 29 0.0063
173 SLEEP DISORDER 441 0.0062
174 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 106 0.0062
175 GENERAL SYMPTOM 46 0.0061
176 BLOOD PRESSURE DIASTOLIC DECREASED 45 0.0061
177 SINUSITIS 606 0.0059
178 GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0059
179 ACUTE GRAFT VERSUS HOST DISEASE 27 0.0059
180 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
181 LOWER RESPIRATORY TRACT CONGESTION 10 0.0059
182 RHEUMATOID ARTHRITIS 663 0.0058
183 NAIL DISORDER 51 0.0058
184 MUSCULOSKELETAL PAIN 305 0.0058
185 COLITIS ULCERATIVE 260 0.0058
186 EAR PAIN 113 0.0058
187 VASCULAR RUPTURE 9 0.0058
188 DRUG-INDUCED LIVER INJURY 180 0.0057
189 DRUG SPECIFIC ANTIBODY PRESENT 37 0.0057
190 POLYP 37 0.0056
191 MYOSITIS 50 0.0056
192 UPPER RESPIRATORY TRACT INFECTION 250 0.0054
193 HYPOALBUMINAEMIA 42 0.0054
194 BRONCHIECTASIS 36 0.0053
195 JOINT SWELLING 643 0.0053
196 LEUKAEMIA RECURRENT 9 0.0053
197 PRODUCT LABEL CONFUSION 31 0.0053
198 SPLEEN DISORDER 9 0.0053
199 EXPOSURE TO SARS-COV-2 9 0.0053
200 CUSHINGOID 17 0.0053
201 PREGNANCY 106 0.0053
202 INFECTION 762 0.0053
203 DRY MOUTH 425 0.0052
204 BLOOD CHLORIDE INCREASED 9 0.0052
205 BLOOD PRESSURE SYSTOLIC INCREASED 101 0.0052
206 GENERAL PHYSICAL HEALTH DETERIORATION 595 0.0051
207 ERYTHEMA NODOSUM 18 0.0051
208 ACUTE MYELOID LEUKAEMIA RECURRENT 11 0.0051
209 RESPIRATORY DISORDER 151 0.0050
210 RECTAL HAEMORRHAGE 216 0.0050
211 LIMB MASS 11 0.0050
212 ANGIOPATHY 28 0.0050
213 HYPOPHYSITIS 10 0.0050
214 HYPOVOLAEMIA 29 0.0050
215 OXYGEN SATURATION ABNORMAL 14 0.0049
216 LARGE INTESTINE POLYP 34 0.0049
217 STAPHYLOCOCCAL SEPSIS 24 0.0049
218 LYMPH NODE PAIN 9 0.0048
219 URTICARIA 810 0.0048
220 INTESTINAL RESECTION 26 0.0048
221 AMNESIA 314 0.0048
222 BODY TEMPERATURE FLUCTUATION 10 0.0048
223 PROTEIN TOTAL DECREASED 18 0.0048
224 LATENT TUBERCULOSIS 10 0.0048
225 OESOPHAGEAL CANDIDIASIS 19 0.0048
226 INFUSION SITE PRURITUS 15 0.0047
227 FAECAL CALPROTECTIN INCREASED 15 0.0047
228 CHRONIC GRAFT VERSUS HOST DISEASE 17 0.0047
229 INCORRECT DRUG ADMINISTRATION RATE 20 0.0047
230 SHOCK HAEMORRHAGIC 38 0.0047
231 APHTHOUS ULCER 36 0.0046
232 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219 0.0046
233 PNEUMATOSIS INTESTINALIS 13 0.0046
234 HYPERSENSITIVITY 840 0.0045
235 THERAPY NON-RESPONDER 203 0.0045
236 HYPOAESTHESIA 673 0.0045
237 PNEUMOCYSTIS JIROVECI PNEUMONIA 10 0.0045
238 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 10 0.0045
239 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
240 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
241 SYSTEMIC CANDIDA 11 0.0044
242 CROHN'S DISEASE 30 0.0044
243 CREPITATIONS 13 0.0044
244 CONTUSION 419 0.0043
245 PLEURITIC PAIN 12 0.0043
246 INFUSION SITE EXTRAVASATION 27 0.0043
247 FEBRILE NEUTROPENIA 287 0.0043
248 DRUG LEVEL DECREASED 44 0.0043
249 GASTROINTESTINAL DISORDER 384 0.0043
250 ANAL ABSCESS 23 0.0043
251 BODY TEMPERATURE DECREASED 42 0.0043
252 RHINITIS 34 0.0042
253 BLOOD IRON DECREASED 50 0.0042
254 BREAST CANCER STAGE I 39 0.0042
255 TUMOUR LYSIS SYNDROME 37 0.0042
256 POLYARTHRITIS 22 0.0042
257 DRUG INTOLERANCE 403 0.0042
258 CYTOMEGALOVIRUS INFECTION 69 0.0041
259 ANAPHYLACTOID REACTION 17 0.0041
260 MATERNAL EXPOSURE DURING PREGNANCY 368 0.0041
261 BRONCHOPULMONARY ASPERGILLOSIS 32 0.0041
262 RHINOVIRUS INFECTION 16 0.0041
263 FEELING HOT 251 0.0041
264 HYPERTENSION 866 0.0041
265 ANAPHYLACTIC SHOCK 105 0.0041
266 MEDICATION ERROR 226 0.0041
267 HISTIOCYTOSIS HAEMATOPHAGIC 12 0.0040
268 WHITE BLOOD CELL COUNT INCREASED 155 0.0040
269 GINGIVAL PAIN 32 0.0040
270 TREATMENT FAILURE 331 0.0040
271 ASPERGILLUS INFECTION 26 0.0040
272 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
273 FINGER DEFORMITY 19 0.0039
274 FISTULA 44 0.0039
275 BACK INJURY 42 0.0039
276 INGROWING NAIL 9 0.0038
277 BODY TEMPERATURE INCREASED 77 0.0038
278 EXPOSURE DURING PREGNANCY 234 0.0038
279 PAROSMIA 28 0.0037
280 THROMBOTIC MICROANGIOPATHY 36 0.0037
281 UVEITIS 50 0.0037
282 WEIGHT INCREASED 825 0.0037
283 OXYGEN SATURATION DECREASED 207 0.0037
284 ARTHRITIS 289 0.0037
285 SHOCK 84 0.0036
286 ADVERSE REACTION 48 0.0036
287 GRAFT VERSUS HOST DISEASE 26 0.0036
288 RED CELL DISTRIBUTION WIDTH INCREASED 15 0.0036
289 STEM CELL TRANSPLANT 9 0.0036
290 SEPTIC SHOCK 156 0.0036
291 OEDEMA PERIPHERAL 434 0.0036
292 ABDOMINAL DISCOMFORT 590 0.0035
293 BRONCHOSPASM 50 0.0035
294 CANDIDIASIS 14 0.0035
295 CYSTITIS HAEMORRHAGIC 14 0.0035
296 CARDIAC MURMUR 30 0.0035
297 HEART RATE DECREASED 121 0.0034
298 VENOOCCLUSIVE LIVER DISEASE 17 0.0034
299 THERAPEUTIC REACTION TIME DECREASED 10 0.0034
300 TACHYCARDIA 304 0.0034
301 MULTI-ORGAN FAILURE 59 0.0034
302 ULCER HAEMORRHAGE 23 0.0034
303 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 9 0.0034
304 PERIPHERAL SWELLING 508 0.0033
305 ENTEROCOLITIS 19 0.0033
306 PYREXIA 1136 0.0033
307 ASTHMA 371 0.0033
308 NASOPHARYNGITIS 602 0.0033
309 OBSTRUCTION 13 0.0033
310 HYPOKALAEMIA 150 0.0032
311 LYMPHOCYTE COUNT DECREASED 57 0.0032
312 CONFUSIONAL STATE 520 0.0032
313 ATELECTASIS 31 0.0032
314 BLOOD CREATININE DECREASED 10 0.0032
315 ANAL FISTULA 17 0.0032
316 DRUG TOLERANCE 16 0.0032
317 MUSCULAR WEAKNESS 359 0.0032
318 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
319 MIGRAINE 296 0.0031
320 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0031
321 CHOLANGITIS 19 0.0031
322 PYODERMA GANGRENOSUM 11 0.0031
323 ESCHERICHIA INFECTION 25 0.0030
324 DYSPEPSIA 298 0.0030
325 HYPERTRANSAMINASAEMIA 21 0.0030
326 CONDITION AGGRAVATED 918 0.0030
327 HYPERNATRAEMIA 15 0.0030
328 PANCREATITIS 159 0.0030
329 ANAPHYLACTIC REACTION 166 0.0030
330 HYPOPHOSPHATAEMIA 22 0.0030
331 EMPHYSEMA 30 0.0030
332 HEART RATE IRREGULAR 67 0.0030
333 ABSCESS 47 0.0029
334 HYPOMAGNESAEMIA 41 0.0029
335 MUSCLE SPASTICITY 36 0.0029
336 IMPAIRED QUALITY OF LIFE 42 0.0029
337 HYPERURICAEMIA 12 0.0029
338 JOINT EFFUSION 20 0.0029
339 BLOOD PRESSURE SYSTOLIC DECREASED 13 0.0029
340 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
341 BACTERIAL INFECTION 53 0.0028
342 ENTERITIS 18 0.0028
343 WOUND SECRETION 11 0.0028
344 RESPIRATORY ACIDOSIS 11 0.0028
345 BRONCHITIS 207 0.0028
346 UNDERDOSE 204 0.0028
347 PNEUMONIA FUNGAL 11 0.0028
348 BLOOD ALBUMIN DECREASED 22 0.0028
349 PHARYNGITIS STREPTOCOCCAL 30 0.0028
350 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 14 0.0028
351 MONOCYTE COUNT INCREASED 10 0.0028
352 HYDROCEPHALUS 15 0.0028
353 COELIAC DISEASE 27 0.0027
354 GASTROENTERITIS 40 0.0027
355 SUSPECTED COVID-19 9 0.0027
356 FACE OEDEMA 46 0.0027
357 HAEMOLYSIS 21 0.0027
358 RESPIRATORY RATE INCREASED 24 0.0027
359 MENINGITIS 18 0.0027
360 PSEUDOMONAS INFECTION 23 0.0027
361 NEUTROPHIL COUNT DECREASED 109 0.0027
362 TONGUE ULCERATION 9 0.0027
363 ALOPECIA 522 0.0027
364 CHEST PAIN 491 0.0026
365 GASTROINTESTINAL PERFORATION 11 0.0026
366 LABORATORY TEST ABNORMAL 78 0.0026
367 SYNOVIAL CYST 12 0.0026
368 BLOOD LACTATE DEHYDROGENASE INCREASED 41 0.0026
369 PNEUMOTHORAX 41 0.0026
370 PHARYNGITIS 32 0.0026
371 VISUAL IMPAIRMENT 319 0.0026
372 TASTE DISORDER 52 0.0026
373 TYPE I HYPERSENSITIVITY 9 0.0026
374 PULMONARY HAEMORRHAGE 20 0.0026
375 PRODUCT ADMINISTRATION INTERRUPTED 20 0.0025
376 BLOOD PRESSURE DECREASED 169 0.0025
377 INFUSION SITE SWELLING 16 0.0025
378 RESPIRATORY DISTRESS 70 0.0025
379 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
380 THROAT IRRITATION 112 0.0025
381 GINGIVAL SWELLING 11 0.0025
382 PRODUCT USE ISSUE 468 0.0025
383 ABDOMINAL ABSCESS 11 0.0025
384 ENTEROCOCCAL INFECTION 12 0.0025
385 BLOOD BILIRUBIN INCREASED 67 0.0025
386 CLOSTRIDIUM DIFFICILE INFECTION 54 0.0025
387 BLOOD LACTIC ACID INCREASED 13 0.0025
388 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
389 GENERALISED ERYTHEMA 14 0.0025
390 WEIGHT DECREASED 687 0.0025
391 BACK DISORDER 40 0.0025
392 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 175 0.0025
393 CARDIAC FAILURE ACUTE 16 0.0024
394 BLOOD UREA INCREASED 40 0.0024
395 FEELING OF BODY TEMPERATURE CHANGE 14 0.0024
396 KLEBSIELLA INFECTION 12 0.0024
397 INTESTINAL STENOSIS 10 0.0024
398 CLOSTRIDIAL INFECTION 8 0.0024
399 LIP OEDEMA 10 0.0024
400 BACTERAEMIA 28 0.0024
401 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
402 PALLOR 64 0.0023
403 VAGINAL INFECTION 11 0.0023
404 PROCTALGIA 15 0.0023
405 THROAT TIGHTNESS 63 0.0023
406 OROPHARYNGEAL DISCOMFORT 21 0.0023
407 HAEMATOCHEZIA 128 0.0023
408 MYOPATHY 20 0.0023
409 SUBCUTANEOUS ABSCESS 11 0.0023
410 VENOUS THROMBOSIS 9 0.0023
411 PNEUMONIA 741 0.0023
412 HEPATIC FUNCTION ABNORMAL 85 0.0023
413 BONE MARROW FAILURE 46 0.0023
414 CEREBRAL ATROPHY 9 0.0023
415 TRANSPLANT REJECTION 18 0.0022
416 RHINITIS ALLERGIC 10 0.0022
417 CONJUNCTIVAL HYPERAEMIA 8 0.0022
418 MEMORY IMPAIRMENT 308 0.0022
419 RASH 974 0.0022
420 MENINGITIS ASEPTIC 10 0.0022
421 GINGIVITIS 12 0.0022
422 FLUSHING 226 0.0022
423 MUCOUS STOOLS 11 0.0022
424 BLOOD ALKALINE PHOSPHATASE INCREASED 55 0.0022
425 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49 0.0022
426 CHEST DISCOMFORT 226 0.0022
427 THROMBOCYTOPENIA 245 0.0022
428 HYPOXIA 77 0.0022
429 PNEUMONIA BACTERIAL 20 0.0022
430 PRURITUS 837 0.0022
431 PARAESTHESIA 342 0.0022
432 LARGE INTESTINE PERFORATION 15 0.0022
433 DECREASED APPETITE 500 0.0022
434 TENDON DISORDER 14 0.0021
435 ATRIAL FLUTTER 17 0.0021
436 ASPARTATE AMINOTRANSFERASE INCREASED 113 0.0021
437 EPILEPSY 65 0.0021
438 MUSCLE SPASMS 390 0.0021
439 SEPSIS 237 0.0021
440 THERAPEUTIC RESPONSE SHORTENED 70 0.0021
441 ABDOMINAL PAIN 490 0.0021
442 PULSE ABSENT 10 0.0021
443 HYPERTHERMIA 16 0.0021
444 BLOOD PRESSURE INCREASED 319 0.0021
445 FEELING COLD 58 0.0021
446 FAECAL INCONTINENCE 10 0.0021
447 RALES 12 0.0021
448 TACHYPNOEA 28 0.0021
449 INSOMNIA 546 0.0020
450 SEASONAL ALLERGY 29 0.0020
451 MOUTH HAEMORRHAGE 15 0.0020
452 CYTOKINE RELEASE SYNDROME 41 0.0020
453 ADVERSE EVENT 188 0.0020
454 BREATH SOUNDS ABNORMAL 10 0.0020
455 ARTHRALGIA 840 0.0020
456 ULCER 32 0.0020
457 PLATELET COUNT DECREASED 214 0.0020
458 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
459 VEIN DISORDER 10 0.0020
460 PNEUMOCYSTIS JIROVECII PNEUMONIA 20 0.0020
461 PANCYTOPENIA 111 0.0020
462 VASCULAR DEVICE INFECTION 9 0.0020
463 GAIT DISTURBANCE 379 0.0020
464 FUNGAL INFECTION 66 0.0020
465 HYPOGAMMAGLOBULINAEMIA 13 0.0020
466 CYANOSIS 31 0.0020
467 MALNUTRITION 22 0.0020
468 VOMITING 922 0.0020
469 VIRAL INFECTION 65 0.0020
470 PAIN IN EXTREMITY 575 0.0019
471 OFF LABEL USE 1694 0.0019
472 HYPERGLYCAEMIA 70 0.0019
473 FACIAL PAIN 17 0.0019
474 ABDOMINAL PAIN UPPER 392 0.0019
475 ADVERSE DRUG REACTION 169 0.0019
476 IMMUNODEFICIENCY 28 0.0019
477 IMPAIRED WORK ABILITY 40 0.0019
478 DEPRESSION 424 0.0019
479 COVID-19 PNEUMONIA 22 0.0019
480 INFUSION SITE PAIN 24 0.0019
481 DRUG ERUPTION 33 0.0019
482 DEFAECATION URGENCY 13 0.0019
483 DECUBITUS ULCER 15 0.0018
484 NASAL CONGESTION 108 0.0018
485 ACIDOSIS 14 0.0018
486 HEPATITIS B 11 0.0018
487 RESPIRATORY FAILURE 133 0.0018
488 ERYTHEMA MULTIFORME 17 0.0018
489 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
490 FLANK PAIN 17 0.0018
491 HEART RATE INCREASED 179 0.0018
492 ORAL HERPES 35 0.0018
493 DYSPNOEA 1011 0.0018
494 LARYNGEAL OEDEMA 11 0.0018
495 SKIN INFECTION 20 0.0018
496 ANAL INCONTINENCE 16 0.0018
497 GENERALISED OEDEMA 22 0.0018
498 POSTOPERATIVE WOUND INFECTION 12 0.0018
499 TOXIC ENCEPHALOPATHY 9 0.0018
500 ALANINE AMINOTRANSFERASE INCREASED 109 0.0018
501 PHLEBITIS 9 0.0018
502 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 313 0.0017
503 BLOOD URIC ACID INCREASED 10 0.0017
504 TENDERNESS 18 0.0017
505 ARTHRITIS INFECTIVE 8 0.0017
506 APLASTIC ANAEMIA 9 0.0017
507 CANDIDA INFECTION 29 0.0017
508 URINE OUTPUT DECREASED 15 0.0017
509 CHILLS 201 0.0017
510 PLEURAL EFFUSION 104 0.0017
511 SERUM FERRITIN INCREASED 9 0.0017
512 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
513 HERPES SIMPLEX 11 0.0017
514 PERICARDIAL EFFUSION 39 0.0017
515 HYPERKALAEMIA 59 0.0017
516 NEUTROPENIC SEPSIS 12 0.0017
517 CONGENITAL ANOMALY 13 0.0017
518 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
519 ANXIETY 475 0.0017
520 TOOTH INFECTION 22 0.0017
521 HYPOTENSION 334 0.0017
522 HAEMATOCRIT DECREASED 33 0.0017
523 NEUTROPHIL COUNT INCREASED 17 0.0017
524 TUBULOINTERSTITIAL NEPHRITIS 31 0.0017
525 HYPOCALCAEMIA 31 0.0016
526 CELLULITIS 82 0.0016
527 PRODUCT USE IN UNAPPROVED INDICATION 402 0.0016
528 WHITE BLOOD CELL COUNT DECREASED 175 0.0016
529 HEART RATE ABNORMAL 9 0.0016
530 ACUTE RESPIRATORY FAILURE 31 0.0016
531 ABDOMINAL TENDERNESS 8 0.0016
532 DIARRHOEA HAEMORRHAGIC 15 0.0016
533 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
534 BRAIN OEDEMA 20 0.0016
535 RENAL FAILURE ACUTE 67 0.0016
536 CYSTITIS 50 0.0016
537 MOUTH ULCERATION 33 0.0016
538 PULMONARY TOXICITY 11 0.0016
539 PAIN 955 0.0016
540 SINUS TACHYCARDIA 22 0.0015
541 STRESS CARDIOMYOPATHY 9 0.0015
542 TOOTH FRACTURE 17 0.0015
543 INFUSION SITE ERYTHEMA 13 0.0015
544 ILEUS 19 0.0015
545 MYELODYSPLASTIC SYNDROME 22 0.0015
546 LIGAMENT SPRAIN 15 0.0015
547 HEADACHE 945 0.0015
548 MALAISE 661 0.0015
549 LEUKOPENIA 74 0.0015
550 DEEP VEIN THROMBOSIS 96 0.0015
551 HYDRONEPHROSIS 11 0.0015
552 MATERNAL EXPOSURE BEFORE PREGNANCY 10 0.0015
553 PSORIASIS 191 0.0015
554 ECCHYMOSIS 10 0.0015
555 PLATELET COUNT INCREASED 19 0.0015
556 VENTRICULAR TACHYCARDIA 24 0.0015
557 SPINAL COMPRESSION FRACTURE 12 0.0014
558 FATIGUE 1130 0.0014
559 RESPIRATION ABNORMAL 10 0.0014
560 OLIGURIA 9 0.0014
561 ORAL CANDIDIASIS 19 0.0014
562 DIARRHOEA 930 0.0014
563 PETECHIAE 15 0.0014
564 TOOTHACHE 26 0.0014
565 LIPASE INCREASED 11 0.0014
566 DEVICE RELATED INFECTION 22 0.0014
567 HEPATIC FAILURE 43 0.0014
568 GASTRIC ULCER 27 0.0014
569 CHOLECYSTITIS ACUTE 8 0.0014
570 ACUTE MYELOID LEUKAEMIA 22 0.0014
571 OVARIAN CYST 14 0.0014
572 COLITIS 53 0.0014
573 HYPOAESTHESIA ORAL 21 0.0014
574 CYTOPENIA 17 0.0014
575 PYELONEPHRITIS 12 0.0014
576 TRICUSPID VALVE INCOMPETENCE 11 0.0014
577 ABDOMINAL PAIN LOWER 35 0.0014
578 OROPHARYNGEAL PAIN 128 0.0014
579 ELECTROLYTE IMBALANCE 16 0.0014
580 EYELID OEDEMA 16 0.0014
581 VASCULITIS 16 0.0014
582 ASTHENIA 516 0.0014
583 ASPIRATION 15 0.0014
584 PULMONARY CONGESTION 18 0.0014
585 EAR DISCOMFORT 14 0.0014
586 LUNG INFILTRATION 12 0.0014
587 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
588 HYPERBILIRUBINAEMIA 14 0.0014
589 VENTRICULAR FIBRILLATION 15 0.0013
590 GASTROINTESTINAL INFECTION 12 0.0013
591 COLITIS ISCHAEMIC 9 0.0013
592 RED BLOOD CELL COUNT DECREASED 38 0.0013
593 NECK PAIN 74 0.0013
594 FLUID RETENTION 67 0.0013
595 SWOLLEN TONGUE 41 0.0013
596 INSURANCE ISSUE 20 0.0013
597 BOWEL MOVEMENT IRREGULARITY 10 0.0013
598 CARDIOMEGALY 16 0.0013
599 RENAL FAILURE CHRONIC 10 0.0013
600 LYMPHOMA 20 0.0013
601 CONCUSSION 10 0.0013
602 ERYTHEMA 265 0.0013
603 SKIN LACERATION 14 0.0013
604 BLOOD CREATININE INCREASED 84 0.0013
605 TOOTH ABSCESS 13 0.0013
606 GASTROINTESTINAL INFLAMMATION 10 0.0013
607 STAPHYLOCOCCAL INFECTION 42 0.0013
608 DIZZINESS 635 0.0013
609 NAUSEA 1001 0.0013
610 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
611 STEVENS-JOHNSON SYNDROME 28 0.0013
612 CARDIOGENIC SHOCK 18 0.0013
613 VENTRICULAR EXTRASYSTOLES 13 0.0013
614 PARAESTHESIA ORAL 18 0.0012
615 PANIC REACTION 9 0.0012
616 SINUS BRADYCARDIA 12 0.0012
617 FAECES SOFT 9 0.0012
618 HERPES ZOSTER 71 0.0012
619 RESPIRATORY ARREST 34 0.0012
620 UTERINE LEIOMYOMA 9 0.0012
621 HAEMORRHOIDS 24 0.0012
622 GASTROOESOPHAGEAL REFLUX DISEASE 99 0.0012
623 CEREBRAL INFARCTION 30 0.0012
624 ORAL DISORDER 9 0.0012
625 RENAL TUBULAR NECROSIS 12 0.0012
626 SMALL INTESTINAL OBSTRUCTION 15 0.0012
627 LYMPHADENOPATHY 43 0.0012
628 HEREDITARY ANGIOEDEMA 13 0.0012
629 NEOPLASM PROGRESSION 42 0.0012
630 BLOOD PRESSURE ABNORMAL 24 0.0012
631 SKIN LESION 33 0.0012
632 LYMPHOPENIA 17 0.0012
633 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
634 EOSINOPHIL COUNT INCREASED 10 0.0012
635 RASH PRURITIC 65 0.0012
636 NEUROTOXICITY 21 0.0012
637 DERMATITIS ALLERGIC 15 0.0012
638 SUBDURAL HAEMATOMA 17 0.0012
639 SENSATION OF FOREIGN BODY 10 0.0012
640 PULMONARY OEDEMA 53 0.0012
641 MELAENA 26 0.0012
642 CHOLECYSTITIS 14 0.0012
643 BACK PAIN 272 0.0012
644 ANAEMIA 223 0.0012
645 ECZEMA 61 0.0012
646 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
647 INTESTINAL PERFORATION 13 0.0012
648 PRODUCTIVE COUGH 55 0.0012
649 TORSADE DE POINTES 9 0.0011
650 ENCEPHALOPATHY 28 0.0011
651 DERMATITIS CONTACT 13 0.0011
652 COLD SWEAT 20 0.0011
653 EATING DISORDER 24 0.0011
654 HAEMOLYTIC ANAEMIA 10 0.0011
655 INTERSTITIAL LUNG DISEASE 54 0.0011
656 EPISTAXIS 83 0.0011
657 PHARYNGEAL OEDEMA 17 0.0011
658 HAEMATEMESIS 28 0.0011
659 HYPONATRAEMIA 62 0.0011
660 HICCUPS 9 0.0011
661 HEPATITIS 28 0.0011
662 GASTROINTESTINAL PAIN 12 0.0011
663 DRUG LEVEL INCREASED 18 0.0011
664 COUGH 304 0.0011
665 SECOND PRIMARY MALIGNANCY 9 0.0011
666 PNEUMONIA ASPIRATION 27 0.0011
667 NODULE 14 0.0011
668 HAEMODIALYSIS 9 0.0011
669 RENAL IMPAIRMENT 90 0.0011
670 CARPAL TUNNEL SYNDROME 15 0.0011
671 MUCOSAL INFLAMMATION 28 0.0011
672 PREMATURE DELIVERY 17 0.0011
673 INJECTION SITE REACTION 73 0.0011
674 INFLUENZA 118 0.0011
675 THERAPEUTIC RESPONSE DECREASED 64 0.0011
676 GASTROENTERITIS VIRAL 19 0.0011
677 HAEMATURIA 36 0.0011
678 LIP SWELLING 35 0.0010
679 LEUKOCYTOSIS 19 0.0010
680 OSTEOMYELITIS 19 0.0010
681 COVID-19 184 0.0010
682 CYST 13 0.0010
683 TOOTH EXTRACTION 13 0.0010
684 NEUTROPENIA 142 0.0010
685 SECRETION DISCHARGE 13 0.0010
686 RENAL PAIN 11 0.0010
687 CHOLELITHIASIS 34 0.0010
688 HAEMOGLOBIN DECREASED 106 0.0010
689 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
690 URINARY TRACT INFECTION 175 0.0010
691 SPLENOMEGALY 12 0.0010
692 IMMUNOSUPPRESSION 9 0.0010
693 COAGULOPATHY 17 0.0010
694 INTENTIONAL DOSE OMISSION 29 0.0010
695 DIABETES MELLITUS 77 0.0010
696 CARDIAC FAILURE 81 0.0010
697 HYPERLIPIDAEMIA 12 0.0010
698 GOUT 18 0.0010
699 HYPOTONIA 10 0.0010
700 RESPIRATORY TRACT INFECTION 26 0.0010
701 CIRCULATORY COLLAPSE 17 0.0010
702 PNEUMONITIS 27 0.0010
703 TINNITUS 45 0.0010
704 RHINORRHOEA 63 0.0010
705 PALPITATIONS 114 0.0010
706 KIDNEY INFECTION 19 0.0010
707 SWELLING FACE 63 0.0010
708 PERITONITIS 20 0.0010
709 RASH ERYTHEMATOUS 46 0.0010
710 BRADYCARDIA 51 0.0010
711 HEAD DISCOMFORT 17 0.0010
712 ABDOMINAL DISTENSION 100 0.0010
713 ARTERIOSCLEROSIS 9 0.0010
714 BLOOD SODIUM DECREASED 18 0.0010
715 GASTRITIS 25 0.0009
716 SPUTUM DISCOLOURED 9 0.0009
717 NEPHROLITHIASIS 43 0.0009
718 PANCREATITIS ACUTE 21 0.0009
719 RENAL FAILURE 124 0.0009
720 CARDIAC ARREST 77 0.0009
721 HAEMOPTYSIS 26 0.0009
722 BLOOD MAGNESIUM DECREASED 8 0.0009
723 DYSURIA 34 0.0009
724 CATARACT 55 0.0009
725 SKIN REACTION 13 0.0009
726 DEHYDRATION 123 0.0009
727 GASTROINTESTINAL HAEMORRHAGE 77 0.0009
728 LIMB INJURY 25 0.0009
729 HEPATOMEGALY 9 0.0009
730 PULMONARY HYPERTENSION 19 0.0009
731 PHOTOPHOBIA 17 0.0009
732 ACCIDENTAL OVERDOSE 33 0.0009
733 INTESTINAL OBSTRUCTION 34 0.0009
734 BASAL CELL CARCINOMA 14 0.0009
735 ATRIAL FIBRILLATION 87 0.0009
736 BLOOD CALCIUM DECREASED 10 0.0009
737 HYPOTHERMIA 9 0.0009
738 DRY THROAT 9 0.0009
739 POST PROCEDURAL COMPLICATION 17 0.0009
740 MYOCARDIAL ISCHAEMIA 10 0.0009
741 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
742 METABOLIC ACIDOSIS 28 0.0009
743 PERIPHERAL COLDNESS 12 0.0009
744 MUSCULOSKELETAL DISCOMFORT 15 0.0009
745 NEOPLASM 10 0.0009
746 HYPOGLYCAEMIA 42 0.0009
747 BLOOD POTASSIUM DECREASED 26 0.0009
748 RHABDOMYOLYSIS 36 0.0009
749 JAUNDICE 23 0.0009
750 URINARY INCONTINENCE 25 0.0008
751 MYOCLONUS 10 0.0008
752 SKIN CANCER 18 0.0008
753 WRIST FRACTURE 10 0.0008
754 THERAPY PARTIAL RESPONDER 13 0.0008
755 DYSPHAGIA 79 0.0008
756 PREMATURE BABY 25 0.0008
757 RESTLESS LEGS SYNDROME 15 0.0008
758 BONE DISORDER 15 0.0008
759 VERTIGO 50 0.0008
760 FEAR 22 0.0008
761 HYPOTHYROIDISM 26 0.0008
762 TREMOR 135 0.0008
763 NIGHTMARE 28 0.0008
764 DIPLOPIA 21 0.0008
765 AGRANULOCYTOSIS 15 0.0008
766 MUSCLE TIGHTNESS 13 0.0008
767 HYPERHIDROSIS 103 0.0008
768 DYSPNOEA EXERTIONAL 30 0.0008
769 BLOOD URINE PRESENT 15 0.0008
770 MASS 11 0.0008
771 MYOCARDITIS 9 0.0008
772 GALLBLADDER DISORDER 14 0.0008
773 ASCITES 23 0.0008
774 OCULAR HYPERAEMIA 37 0.0008
775 THYROID DISORDER 12 0.0008
776 PAIN IN JAW 22 0.0008
777 ANOREXIA 10 0.0008
778 MUSCULOSKELETAL CHEST PAIN 12 0.0008
779 TENDONITIS 12 0.0008
780 CAESAREAN SECTION 9 0.0008
781 PULMONARY EMBOLISM 73 0.0008
782 SPINAL PAIN 9 0.0008
783 LOSS OF CONSCIOUSNESS 98 0.0008
784 HYPOKINESIA 11 0.0008
785 ILLNESS 77 0.0007
786 HAEMORRHAGE 78 0.0007
787 DECREASED ACTIVITY 8 0.0007
788 CARDIO-RESPIRATORY ARREST 31 0.0007
789 FLATULENCE 42 0.0007
790 DYSGEUSIA 55 0.0007
791 MUSCLE TWITCHING 17 0.0007
792 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
793 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
794 HAEMATOMA 19 0.0007
795 DISORIENTATION 29 0.0007
796 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
797 MANIA 12 0.0007
798 APHASIA 22 0.0007
799 LIVER FUNCTION TEST ABNORMAL 21 0.0007
800 APHONIA 10 0.0007
801 LUNG INFECTION 11 0.0007
802 SINUS DISORDER 14 0.0007
803 ACUTE KIDNEY INJURY 108 0.0007
804 HOSPITALISATION 108 0.0007
805 PRURITUS GENERALISED 15 0.0007
806 RESPIRATORY TRACT CONGESTION 11 0.0007
807 SKIN DISORDER 23 0.0007
808 EOSINOPHILIA 12 0.0007
809 DYSPHONIA 40 0.0007
810 IMMUNE SYSTEM DISORDER 9 0.0007
811 SLEEP APNOEA SYNDROME 13 0.0007
812 SYNCOPE 68 0.0007
813 RASH MACULO-PAPULAR 15 0.0007
814 HEPATOTOXICITY 15 0.0007
815 RENAL INJURY 20 0.0007
816 HERNIA 13 0.0007
817 PULMONARY MASS 10 0.0007
818 QUALITY OF LIFE DECREASED 9 0.0007
819 SNEEZING 15 0.0007
820 EXPIRED PRODUCT ADMINISTERED 22 0.0007
821 LOCALISED INFECTION 16 0.0007
822 DRY EYE 33 0.0007
823 URINARY RETENTION 22 0.0007
824 EYE PAIN 37 0.0007
825 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
826 UPPER LIMB FRACTURE 13 0.0007
827 NERVOUSNESS 34 0.0007
828 HEMIPARESIS 11 0.0006
829 ANHEDONIA 17 0.0006
830 CONSTIPATION 141 0.0006
831 DRUG INEFFECTIVE 851 0.0006
832 ACUTE MYOCARDIAL INFARCTION 19 0.0006
833 CEREBRAL HAEMORRHAGE 23 0.0006
834 OSTEONECROSIS 21 0.0006
835 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
836 VISION BLURRED 87 0.0006
837 RIB FRACTURE 13 0.0006
838 ORTHOSTATIC HYPOTENSION 11 0.0006
839 PRODUCT PRESCRIBING ERROR 15 0.0006
840 BURNING SENSATION 44 0.0006
841 HYPERTHYROIDISM 9 0.0006
842 NEUROPATHY PERIPHERAL 59 0.0006
843 SKIN ULCER 16 0.0006
844 EYE SWELLING 23 0.0006
845 NEURALGIA 15 0.0006
846 BLOOD POTASSIUM INCREASED 10 0.0006
847 SOMNOLENCE 123 0.0006
848 RETCHING 13 0.0006
849 TREATMENT NONCOMPLIANCE 33 0.0006
850 MYALGIA 102 0.0006
851 ANGINA PECTORIS 17 0.0006
852 OSTEOPENIA 9 0.0006
853 HYPERSOMNIA 17 0.0006
854 CONJUNCTIVITIS 11 0.0006
855 HIP FRACTURE 19 0.0006
856 HYPOPHAGIA 15 0.0006
857 DYSARTHRIA 22 0.0006
858 FEMUR FRACTURE 18 0.0006
859 UNRESPONSIVE TO STIMULI 15 0.0006
860 PRESYNCOPE 14 0.0006
861 LETHARGY 33 0.0006
862 RASH MACULAR 20 0.0006
863 BONE PAIN 33 0.0006
864 CONVULSION 32 0.0006
865 AGITATION 41 0.0006
866 POOR QUALITY SLEEP 12 0.0006
867 CRYING 20 0.0005
868 EYE DISORDER 18 0.0005
869 RESTLESSNESS 20 0.0005
870 PHOTOSENSITIVITY REACTION 9 0.0005
871 ANGIOEDEMA 24 0.0005
872 FEEDING DISORDER 11 0.0005
873 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
874 UNEVALUABLE EVENT 41 0.0005
875 CARDIOMYOPATHY 8 0.0005
876 FALL 180 0.0005
877 TOOTH DISORDER 12 0.0005
878 ORAL PAIN 12 0.0005
879 CARDIAC FAILURE CONGESTIVE 43 0.0005
880 THROMBOSIS 43 0.0005
881 LACRIMATION INCREASED 16 0.0005
882 MOVEMENT DISORDER 17 0.0005
883 FOOT FRACTURE 10 0.0005
884 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
885 FEELING JITTERY 10 0.0005
886 DISEASE PROGRESSION 62 0.0005
887 INCREASED APPETITE 10 0.0005
888 OVERDOSE 112 0.0005
889 HOT FLUSH 39 0.0005
890 RENAL DISORDER 24 0.0005
891 JOINT INJURY 11 0.0005
892 METASTASES TO LIVER 9 0.0005
893 INFLUENZA LIKE ILLNESS 42 0.0005
894 EYE PRURITUS 17 0.0005
895 PROCEDURAL PAIN 14 0.0005
896 DRY SKIN 67 0.0005
897 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
898 DRUG EXPOSURE DURING PREGNANCY 17 0.0005
899 MYELOSUPPRESSION 18 0.0005
900 FULL BLOOD COUNT DECREASED 10 0.0005
901 RASH PAPULAR 11 0.0005
902 INCORRECT DOSE ADMINISTERED 112 0.0005
903 HEPATIC STEATOSIS 9 0.0005
904 NERVOUS SYSTEM DISORDER 15 0.0005
905 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
906 SEIZURE 55 0.0005
907 BALANCE DISORDER 41 0.0005
908 COGNITIVE DISORDER 22 0.0005
909 MENTAL STATUS CHANGES 13 0.0005
910 DEMENTIA 13 0.0005
911 ARRHYTHMIA 22 0.0005
912 CORONARY ARTERY DISEASE 14 0.0005
913 COMA 22 0.0005
914 CHOKING 9 0.0005
915 FAECES DISCOLOURED 10 0.0005
916 SKIN DISCOLOURATION 21 0.0005
917 OSTEONECROSIS OF JAW 11 0.0004
918 DIVERTICULITIS 12 0.0004
919 POLLAKIURIA 18 0.0004
920 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
921 FEELING ABNORMAL 101 0.0004
922 PRODUCT QUALITY ISSUE 57 0.0004
923 CHOLESTASIS 8 0.0004
924 DIABETIC KETOACIDOSIS 10 0.0004
925 MENTAL DISORDER 18 0.0004
926 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
927 INTENTIONAL PRODUCT MISUSE 36 0.0004
928 PLASMA CELL MYELOMA 16 0.0004
929 PRODUCT DOSE OMISSION ISSUE 120 0.0004
930 PSYCHOTIC DISORDER 12 0.0004
931 LACTIC ACIDOSIS 13 0.0004
932 CHROMATURIA 9 0.0004
933 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
934 RASH GENERALISED 10 0.0004
935 CEREBROVASCULAR ACCIDENT 65 0.0004
936 IRRITABILITY 23 0.0004
937 ACNE 29 0.0004
938 DISEASE RECURRENCE 18 0.0004
939 SKIN BURNING SENSATION 27 0.0004
940 DISTURBANCE IN ATTENTION 20 0.0004
941 DYSKINESIA 15 0.0004
942 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
943 SPEECH DISORDER 19 0.0004
944 NEOPLASM MALIGNANT 24 0.0004
945 DRUG INTERACTION 57 0.0004
946 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
947 LIMB DISCOMFORT 11 0.0004
948 EYE IRRITATION 20 0.0003
949 DEAFNESS 9 0.0003
950 SKIN EXFOLIATION 29 0.0003
951 DYSSTASIA 10 0.0003
952 CARDIAC DISORDER 32 0.0003
953 NO ADVERSE EVENT 61 0.0003
954 ABASIA 8 0.0003
955 BONE DENSITY DECREASED 10 0.0003
956 BLINDNESS 13 0.0003
957 MOOD SWINGS 10 0.0003
958 BLOOD GLUCOSE DECREASED 15 0.0003
959 ABNORMAL BEHAVIOUR 12 0.0003
960 DEPRESSED MOOD 16 0.0003
961 DEATH 259 0.0003
962 LUNG NEOPLASM MALIGNANT 12 0.0003
963 HEAD INJURY 9 0.0003
964 EMOTIONAL DISTRESS 34 0.0003
965 HYPOACUSIS 12 0.0003
966 BLOOD GLUCOSE INCREASED 50 0.0003
967 DRUG EFFECT DECREASED 14 0.0003
968 ABORTION SPONTANEOUS 10 0.0002
969 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
970 PANIC ATTACK 9 0.0002
971 INJECTION SITE BRUISING 19 0.0002
972 INJECTION SITE PRURITUS 15 0.0002
973 AGGRESSION 11 0.0002
974 SKIN IRRITATION 10 0.0002
975 HALLUCINATION 16 0.0002
976 DEVICE DISLOCATION 9 0.0002
977 SURGERY 12 0.0002
978 SUICIDAL IDEATION 18 0.0002
979 THERAPY INTERRUPTED 14 0.0002
980 MYOCARDIAL INFARCTION 34 0.0002
981 BREAST CANCER 16 0.0002
982 CHRONIC KIDNEY DISEASE 13 0.0002
983 PRODUCT DOSE OMISSION 11 0.0002
984 DEVICE ISSUE 15 0.0002
985 TOXICITY TO VARIOUS AGENTS 26 0.0002
986 INJECTION SITE SWELLING 10 0.0001
987 INJECTION SITE ERYTHEMA 16 0.0001
988 DRUG DOSE OMISSION BY DEVICE 8 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
990 INJECTION SITE PAIN 28 0.0001
991 DRUG DOSE OMISSION 15 0.0001
992 DRUG DEPENDENCE 12 0.0001